IBRX
ImmunityBio, Inc. Common Stock
$6.44
-0.93%
-0.06
Notify me if price changes either direction
Buy IBRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
6.4B
Enterprise value
7.0B
Trailing PE
-10.906779661017
Forward PE
-25.129543
PEG Ratio
0.26176271186441
Enterprise to EBITDA
-28.404
Enterprise to revenue
84.276
Price to book MRQ
-11.637869805697
Price to sales TTM
76.95506
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
82.6M
EBITDA
-244947008
Diluted EPS TTM
-0.41
Total Cash (MRQ)
257.8M
Current ratio (MRQ)
5.767
Operating Cash Flow (TTM)
-319702016
IBRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
